Nurix Therapeutics, Inc. (NRIX) Misses Q1 EPS by 3c

Nurix Therapeutics, Inc. (NASDAQ: NRIX) reported Q1 EPS of ($0.79), $0.03 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $6.25 million versus the consensus estimate of $14.25 million.

For earnings history and earnings-related data on Nurix Therapeutics, Inc. (NRIX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• ZenaTech raises Plurilock Security stake to 12% with new share purchase